Lifecore Biomedical Inc
Cerrado
SectorConsumo defensivo
4.08 -0.24
Resumen
Variación precio
24h
Mínimo
4.04
Máximo
4.16
Ingresos | 9.8M -6.2M |
|---|---|
Ventas | 11M 34M |
Margen de beneficios | -18.017 |
Empleados | 382 |
Próximas Ganancias | 10 dic 2026 |
|---|
Capitalización Mercado | -20M 140M |
|---|---|
Apertura anterior | 4.32 |
Cierre anterior | 4.08 |
Noticias sobre sentimiento de mercado
By Acuity
50%
50%
56 / 130 Clasificación en Consumer defensive
Lifecore Biomedical Inc Gráfico
Resultados pasados no son un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
Lifecore Biomedical Inc previsión
Sentimiento
By Acuity
56 / 130 Clasificación en Consumo defensivo
Noticias sobre sentimiento de mercado
Neutral
Volatilidad
Por debajo de la media
Volumen de Noticias (RCV)
Por encima de la media
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de Lifecore Biomedical Inc
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.